Income Statement

v3.7.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Revenues:        
Chronic illness monitoring supplies revenues $ 1,666,701 $ 1,259,851 $ 3,274,777 $ 3,113,268
Chronic illness monitoring fee revenues 186,794 337,045 440,313 571,298
Total Chronic illness monitoring revenues 1,853,495 1,596,896 3,715,090 3,684,566
Cost of revenues:        
Chronic illness monitoring supplies cost of revenues 1,121,784 1,144,293 2,320,943 2,609,144
Chronic illness monitoring fee cost of revenues 103,238 117,444 204,230 245,950
Total Chronic illness monitoring cost of revenues 1,225,022 1,261,737 2,525,173 2,855,094
Gross profit 628,473 335,159 1,189,917 829,472
Operating expenses:        
Selling, general and administrative (including $627,626, $1,073,481, $639,580 and $2,253,403, respectively, of stock-based compensation) 1,946,678 2,427,790 3,156,975 4,774,494
Research and development 83,338 58,503 250,945 81,412
Total operating expenses 2,030,016 2,486,293 3,407,920 4,855,906
Loss from operations (1,401,543) (2,151,134) (2,218,003) (4,026,434)
Other income (expense):        
Interest expense, net (3,102,211) (630,821) (4,657,627) (1,121,970)
Loss on extinguishment of debt (494,995) (3,043,416) (2,499,212) (3,043,416)
(Loss) gain on disposal of property and equipment   (355)   245
Loss on induced conversions of debt   (379,132)   (379,132)
Gain on liability settlements   286,241   286,241
(Loss) gain on derivatives liability 143,962 (2,853,180) 166,019 (2,806,869)
Total other expense (3,453,244) (6,620,663) (6,990,820) (7,064,901)
Net loss (4,854,787) (8,771,797) (9,208,823) (11,091,335)
Deemed dividends on redemption of preferred stock   (6,484,236)   (6,484,236)
Dividends on preferred stock (34,178) (249,921) (68,356) (653,469)
Net loss attributable to common stockholders $ (4,888,965) $ (15,505,954) $ (9,277,179) $ (18,229,040)
Net loss per common share - basic $ (21.06) $ (90.56) $ (39.97) $ (109.97)
Net loss per common share - diluted $ (21.31) $ (90.56) $ (39.97) $ (109.97)
Weighted average common shares outstanding - basic 232,100 171,223 232,100 165,766
Weighted average common shares outstanding - diluted 232,381 171,223 232,100 165,766

Source